17439_Symbio_AtopicDermatitis_News_Post_D1_V1-thumb

Post navigation

Symbio Releases White Paper: “Atopic Dermatitis – Considerations for Clinical Trials”

Headquartered in Port Jefferson, NY, USA, Symbio is a client-focused global full-service Clinical Research Organization (CRO). We manage all CRO core services in house and have offices in the USA and Europe.

Symbio, LLC 21 Perry Street
Port Jefferson, NY 11777
Tel: (631) 474-8531
Symbio in Europe: SRE GmbH Karl-Breuing-Str. 2
45770 Marl, Germany
Tel: +49 170 205 13 58

Menu

Home
About Symbio
Therapeutic Expertise
Topical Formulation
Sponsors
Investigators
News & Events
Careers
Contact

Join Our Email List

Designed and developed by Progressive Marketing Group, Inc.